Loading…

Fabry disease in a geriatric population

Saved in:

Bibliographic Details
Published in:	Clinical genetics 2015-11, Vol.88 (5), p.499-501
Main Authors:	Barbey, F., Joly, D., Noel, E., Drouineau, O., Krayenbühl, P.-A., Lidove, O.
Format:	Article
Language:	English
Subjects:	Aged Aged, 80 and over alpha-Galactosidase - genetics Cost-Benefit Analysis Enzyme Replacement Therapy - economics Fabry Disease - genetics Fabry Disease - pathology Fabry Disease - therapy Female Humans Male Mutation
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c4615-b563c4bce3c32b0cb69f90f341e909262bacdcdbdce66ca51d133c844f368f383
cites	cdi_FETCH-LOGICAL-c4615-b563c4bce3c32b0cb69f90f341e909262bacdcdbdce66ca51d133c844f368f383
container_end_page	501
container_issue	5
container_start_page	499
container_title	Clinical genetics
container_volume	88
creator	Barbey, F. Joly, D. Noel, E. Drouineau, O. Krayenbühl, P.-A. Lidove, O.
description
doi_str_mv	10.1111/cge.12585
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1721348856</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1721348856</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4615-b563c4bce3c32b0cb69f90f341e909262bacdcdbdce66ca51d133c844f368f383</originalsourceid><addsrcrecordid>eNp1kU1LAzEQhoMotlYP_gFZ8KAe1iabjyZHKW0VagU_6DFks9mSut2tyS7af2902x4E5_Iy8Mw7wzsAnCN4i0L19cLcooRyegC6CAsRQwjJIegGEbFADHfAiffL0OIBFcegE1hGiRBdcDVWqdtEmfVGeRPZMlLRwjiramd1tK7WTaFqW5Wn4ChXhTdnW-2Bt_HodXgfT58mD8O7aawJQzROKcOapNpgjZMU6pSJXMAcE2QEFAlLUqUznaWZNoxpRVGGMNackBwznmOOe-C69V276qMxvpYr67UpClWaqvESDRKECedhTw9c_kGXVePKcF2gkKBYEJ4E6qaltKu8dyaXa2dXym0kgvInPRnSk7_pBfZi69ikK5PtyV1cAei3wKctzOZ_JzmcjHaWcTthfW2-9hPKvUs2CN-Q89lEPs7oM58zIV_wN2BwhdE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1719539482</pqid></control><display><type>article</type><title>Fabry disease in a geriatric population</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Barbey, F. ; Joly, D. ; Noel, E. ; Drouineau, O. ; Krayenbühl, P.-A. ; Lidove, O.</creator><creatorcontrib>Barbey, F. ; Joly, D. ; Noel, E. ; Drouineau, O. ; Krayenbühl, P.-A. ; Lidove, O.</creatorcontrib><identifier>ISSN: 0009-9163</identifier><identifier>EISSN: 1399-0004</identifier><identifier>DOI: 10.1111/cge.12585</identifier><identifier>PMID: 25865499</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Aged ; Aged, 80 and over ; alpha-Galactosidase - genetics ; Cost-Benefit Analysis ; Enzyme Replacement Therapy - economics ; Fabry Disease - genetics ; Fabry Disease - pathology ; Fabry Disease - therapy ; Female ; Humans ; Male ; Mutation</subject><ispartof>Clinical genetics, 2015-11, Vol.88 (5), p.499-501</ispartof><rights>2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4615-b563c4bce3c32b0cb69f90f341e909262bacdcdbdce66ca51d133c844f368f383</citedby><cites>FETCH-LOGICAL-c4615-b563c4bce3c32b0cb69f90f341e909262bacdcdbdce66ca51d133c844f368f383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25865499$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barbey, F.</creatorcontrib><creatorcontrib>Joly, D.</creatorcontrib><creatorcontrib>Noel, E.</creatorcontrib><creatorcontrib>Drouineau, O.</creatorcontrib><creatorcontrib>Krayenbühl, P.-A.</creatorcontrib><creatorcontrib>Lidove, O.</creatorcontrib><title>Fabry disease in a geriatric population</title><title>Clinical genetics</title><addtitle>Clin Genet</addtitle><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>alpha-Galactosidase - genetics</subject><subject>Cost-Benefit Analysis</subject><subject>Enzyme Replacement Therapy - economics</subject><subject>Fabry Disease - genetics</subject><subject>Fabry Disease - pathology</subject><subject>Fabry Disease - therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Mutation</subject><issn>0009-9163</issn><issn>1399-0004</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp1kU1LAzEQhoMotlYP_gFZ8KAe1iabjyZHKW0VagU_6DFks9mSut2tyS7af2902x4E5_Iy8Mw7wzsAnCN4i0L19cLcooRyegC6CAsRQwjJIegGEbFADHfAiffL0OIBFcegE1hGiRBdcDVWqdtEmfVGeRPZMlLRwjiramd1tK7WTaFqW5Wn4ChXhTdnW-2Bt_HodXgfT58mD8O7aawJQzROKcOapNpgjZMU6pSJXMAcE2QEFAlLUqUznaWZNoxpRVGGMNackBwznmOOe-C69V276qMxvpYr67UpClWaqvESDRKECedhTw9c_kGXVePKcF2gkKBYEJ4E6qaltKu8dyaXa2dXym0kgvInPRnSk7_pBfZi69ikK5PtyV1cAei3wKctzOZ_JzmcjHaWcTthfW2-9hPKvUs2CN-Q89lEPs7oM58zIV_wN2BwhdE</recordid><startdate>201511</startdate><enddate>201511</enddate><creator>Barbey, F.</creator><creator>Joly, D.</creator><creator>Noel, E.</creator><creator>Drouineau, O.</creator><creator>Krayenbühl, P.-A.</creator><creator>Lidove, O.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201511</creationdate><title>Fabry disease in a geriatric population</title><author>Barbey, F. ; Joly, D. ; Noel, E. ; Drouineau, O. ; Krayenbühl, P.-A. ; Lidove, O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4615-b563c4bce3c32b0cb69f90f341e909262bacdcdbdce66ca51d133c844f368f383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>alpha-Galactosidase - genetics</topic><topic>Cost-Benefit Analysis</topic><topic>Enzyme Replacement Therapy - economics</topic><topic>Fabry Disease - genetics</topic><topic>Fabry Disease - pathology</topic><topic>Fabry Disease - therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Mutation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barbey, F.</creatorcontrib><creatorcontrib>Joly, D.</creatorcontrib><creatorcontrib>Noel, E.</creatorcontrib><creatorcontrib>Drouineau, O.</creatorcontrib><creatorcontrib>Krayenbühl, P.-A.</creatorcontrib><creatorcontrib>Lidove, O.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barbey, F.</au><au>Joly, D.</au><au>Noel, E.</au><au>Drouineau, O.</au><au>Krayenbühl, P.-A.</au><au>Lidove, O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fabry disease in a geriatric population</atitle><jtitle>Clinical genetics</jtitle><addtitle>Clin Genet</addtitle><date>2015-11</date><risdate>2015</risdate><volume>88</volume><issue>5</issue><spage>499</spage><epage>501</epage><pages>499-501</pages><issn>0009-9163</issn><eissn>1399-0004</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>25865499</pmid><doi>10.1111/cge.12585</doi><tpages>3</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0009-9163
ispartof	Clinical genetics, 2015-11, Vol.88 (5), p.499-501
issn	0009-9163 1399-0004
language	eng
recordid	cdi_proquest_miscellaneous_1721348856
source	Wiley-Blackwell Read & Publish Collection
subjects	Aged Aged, 80 and over alpha-Galactosidase - genetics Cost-Benefit Analysis Enzyme Replacement Therapy - economics Fabry Disease - genetics Fabry Disease - pathology Fabry Disease - therapy Female Humans Male Mutation
title	Fabry disease in a geriatric population
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T17%3A16%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fabry%20disease%20in%20a%20geriatric%20population&rft.jtitle=Clinical%20genetics&rft.au=Barbey,%20F.&rft.date=2015-11&rft.volume=88&rft.issue=5&rft.spage=499&rft.epage=501&rft.pages=499-501&rft.issn=0009-9163&rft.eissn=1399-0004&rft_id=info:doi/10.1111/cge.12585&rft_dat=%3Cproquest_cross%3E1721348856%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4615-b563c4bce3c32b0cb69f90f341e909262bacdcdbdce66ca51d133c844f368f383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1719539482&rft_id=info:pmid/25865499&rfr_iscdi=true